Pediatric Cardiology

, 32:953 | Cite as

Early NT-proBNP Is Able to Predict Spontaneous Closure of Patent Ductus Arteriosus in Preterm Neonates, But Not the Need of Its Treatment

  • D. MartinoviciEmail author
  • S. Vanden Eijnden
  • P. Unger
  • B. Najem
  • B. Gulbis
  • Y. Maréchal
Original Article


The objective of this study was to establish the potential utility of N-terminal pro-brain natriuretic peptide (NT-proBNP) in the management of patent ductus arteriosus (PDA). This was a monocentric prospective blind study that was conducted in a referral neonatal intensive care unit. The patients were very low-birth-weight/gestational-age neonates. Babies with cardiac congenital anomaly other than PDA, life-threatening congenital malformation, severe asphyxia at birth, persistent pulmonary hypertension, and death within the first week of life were excluded. Plasma NT-proBNP concentrations were determined on days 2, 4, and 7 of life. Echocardiography was performed on days 4 and 7. Results were blinded to clinicians. Only echographic results were available upon request. Thirty-one infants were included. NT-proBNP levels were significantly correlated to ductal size and to left atrial-to-aortic diameter ratio. The median NT-proBNP on both days 2 and 4 was significantly higher in neonates with later treated or persistent PDA. A level above 10.000 pg/mL at 48 h of age yielded a 100% positive and a 87% negative predictive value to exclude spontaneous ductal closure. However, no NT-proBNP threshold could predict which PDA would be judged necessary to treat. It was concluded that early low NT-proBNP values can be used as a reliable independent marker to predict spontaneous ductal closure in preterm neonates. Yet, high NT-proBNP levels should not be used to guide the decision to treat PDA, the risk being of treating many bystanding PDAs.


NT-proBNP PDA Preterm 



We would like to thank Prof. Anne Pardou, former head of our NICU who encouraged our research, Prof. Bart Van Overmeire for his precious help in reviewing the manuscript, and all of the clinicians involved in the care of our babies. Philippe Unger has received a grant from the “Fonds pour la Chirurgie Cardiaque.”


  1. 1.
    Attridge JT, Kaufman DA, Lim DS (2009) B-Type natriuretic peptide concentrations to guide treatment of patent ductus arteriosus. Arch Dis Child Fetal Neonatal Ed 94:F178–F182PubMedCrossRefGoogle Scholar
  2. 2.
    Benitz WE (2010) Treatment of persistent ductus arteriosus in preterm infants: time to accept the null hypothesis? J Perinatol 30:241–252PubMedCrossRefGoogle Scholar
  3. 3.
    Chiruvolu A, Jaleel MA (2009) Therapeutic management of patent ductus arteriosus. Early Hum Dev 85(3):151–155PubMedCrossRefGoogle Scholar
  4. 4.
    Clyman RI (2000) Ibuprofen and patent ductus arteriosus. N Engl J Med 343(10):728–730PubMedCrossRefGoogle Scholar
  5. 5.
    El Hajjar M, Vaksmann G, Rakza T, Kongolo G, Storme L (2005) Severity of the ductal shunt: a comparison of different markers. Arch Dis Child Fetal Neonatal Ed 90:F419–F422PubMedCrossRefGoogle Scholar
  6. 6.
    El-Khuffash A, Davis PG, Walsh K, Molloy EJ (2008) Cardiac troponin T and N-terminal-pro-B natriuretic peptide reflect myocardial function in preterm infants. J Perinatol 28(7):482–486PubMedCrossRefGoogle Scholar
  7. 7.
    Farombi-Oghuvbu I, Matthews T, Mayne PD, Guerin H, Corcoran JD (2008) N-Terminal pro-B-type natriuretic peptide: a measure of significant patent ductus arteriosus. Arch Dis Child Fetal Neonatal Ed 93:F257–F260PubMedCrossRefGoogle Scholar
  8. 8.
    Fowlie PW, Davis PG, McGuire W (2010) Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants. Cochrane Database Syst Rev 7:CD000174PubMedGoogle Scholar
  9. 9.
    Hamrick SEG, Hansmann G (2010) Patent ductus arteriosus of the preterm infant. Pediatrics 125(5):1019–1030CrossRefGoogle Scholar
  10. 10.
    Herrman K, Bose C, Lewis K, Laughon M (2009) Spontaneous closure of the patent ductus arteriosus in very low birth weight infants following discharge from the neonatal unit. Arch Dis Child Fetal Neonatal Ed 94(1):F48–F50PubMedCrossRefGoogle Scholar
  11. 11.
    Keane JF, Fyler DC (2006) Patent ductus arteriosus. In: Keane JF, Lock JE, Fyler DC (eds) Nadas’ pediatric cardiology, 2nd edn. Saunders/Elsevier, Philadelphia, pp 617–625Google Scholar
  12. 12.
    Koch J, Hensley G, Roy L, Brown S, Ramaciotti C, Rosenfeld CR (2006) Prevalence of spontaneous closure of the ductus arteriosus in neonates at a birth weight of 1000 grams or less. Pediatrics 117(4):1113–1121PubMedCrossRefGoogle Scholar
  13. 13.
    Lai WW, Geva T, Shirali GS, Frommelt PC, Humes RA, Brook MM, Pignatelli RH, Rychik J, Task Force of the Pediatric Council of the American Society of Echocardiography; Pediatric Council of the American Society of Echocardiography (2006) Guidelines and standards for performance of a pediatric echocardiogram: a report from the Task Force of the Pediatric Council of the American Society of Echocardiography. J Am Soc Echocardiogr 19:1413–1430Google Scholar
  14. 14.
    McNamara PJ, Sehgal A (2007) Towards rational management of patent ductus arteriosus: the need for disease staging. Arch Child Fetal Neonatal Ed 92:F424–F427CrossRefGoogle Scholar
  15. 15.
    Mercanti I, Boubred F, Simeoni U (2009) Therapeutic closure of the ductus arteriosus: benefits and limitations. J Matern Fetal Neonatal 22(Suppl 3):14–20CrossRefGoogle Scholar
  16. 16.
    Nuntnarumit P, Khositseth A, Thanomsingh P (2009) N-Terminal probrain natriuretic peptide and patent ductus arteriosus in preterm infants. J Perinatol 29:137–142PubMedCrossRefGoogle Scholar
  17. 17.
    Ramakrishnan S, Heung YM, Round J, Morris TP, Collinson P, Williams AF (2009) Early N-terminal pro-brain natriuretic peptide measurements predict clinically significant ductus arteriosus in preterm infants. Acta Paediatr 98:1254–1259PubMedCrossRefGoogle Scholar
  18. 18.
    Sehgal A, McNamara PJ (2009) Does echocardiography facilitate determination if hemodynamic significance attributable to ductus arteriosus? Eur J Pediatr 168:907–914PubMedCrossRefGoogle Scholar
  19. 19.
    Skelton R, Evans N, Smythe J (1994) A blinded comparison of clinical and echocardiographical evaluation of the preterm infant for patent ductus arteriosus. J Paediatr Child Health 30:406–411PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  • D. Martinovici
    • 1
    Email author
  • S. Vanden Eijnden
    • 1
  • P. Unger
    • 2
  • B. Najem
    • 2
  • B. Gulbis
    • 3
  • Y. Maréchal
    • 1
  1. 1.Neonatal Intensive Care UnitULB-Erasme HospitalBrusselsBelgium
  2. 2.Department of CardiologyULB-Erasme HospitalBrusselsBelgium
  3. 3.Department of Clinical ChemistryULB-Erasme HospitalBrusselsBelgium

Personalised recommendations